
table of contents
Menopausal insomnia, PMS pain... The "method that works for me" I finally found is about to be taken away
December 28, 2025. For many women, this dateYour last chance to protect your healthThe Ministry of Health, Labor and Welfare is moving forward with a policy to regulate CBN (cannabinol) as a designated drug.Public comment deadline is approaching.
Women suffering from menopausal insomnia, irritability, and PMS pain are on the verge of losing the relief they have long sought. This article provides a comprehensive overview of the background to CBN regulation, the latest scientific evidence, the views of international experts, and what we can do about it.
table of contents
- What is CBN? The scientific evidence for its effectiveness in treating menopausal and PMS symptoms
- History and issues surrounding the 2025 regulations
- Latest research reveals the effects of CBN
- Voices of the people involved, options lost
- Overseas experts talk about harm reduction
- What we can do: A guide to submitting public comments
What is CBN? The scientific evidence for its effectiveness in treating menopausal and PMS symptoms
CBN (Cannabinol) Basics
CBN (Cannabinol)is one of over 100 cannabinoids found in the cannabis plant. It is a compound produced when THC breaks down over time and exposure to light.A mild compound with only about 25% of the psychoactive effects of THC.
| ingredient | psychoactive | Main uses | Legal status (Japan) |
|---|---|---|---|
| CBN | Mild (about 25% THC) | Improved sleep and pain relief | Planned Regulation |
| CBD | Almost none | anti-anxiety, anti-inflammatory | legitimate |
| THC | strong | Medical/Personal Use | Illegal |
Why attention has been paid to menopausal and PMS symptoms
Menopause and PMS symptoms have the following in common:
- Sleeping disorder(Difficulty falling asleep, waking up in the middle of the night)
- Mood swings(irritation, anxiety)
- Physical pain(headache, joint pain)
- hormonal imbalance
CBN can help with these symptoms:Acts through the endocannabinoid system (ECS)The ECS is a bodily system deeply involved in women's health, including sleep, pain, mood, and hormone balance.
Options for women who don't respond to hormone therapy
Hormone replacement therapy (HRT)is the standard treatment for menopausal symptoms, but many women cannot use it for the following reasons:
- Women at high risk of cancer
- Women at risk of heart disease or thrombosis
- Women with liver disease
- Women who cannot tolerate the side effects of HRT
For these women,CBN is one of the few alternativesIt was one of them.
History and Issues of the 2025 CBN Regulation
Market Issues Behind Consideration of CBN Regulation

The reason why CBN regulation is being considered is not only due to the ingredient itself, but also toProblems that arose during the process of market formation in JapanExists.
Cannabinoid products, which are derived from cannabis, require careful information provision and sufficient consideration when being distributed in Japan. However, some businesses prioritize short-term profits and target young people."Hip-hop culture"As a result, it has become commonplace to sell products without fully explaining the risks and prerequisites for use, creating an environment that is conducive to jumping off buildings by young people, such as university students.
Furthermore, exacerbating these problems is theRakuten Market and AmazonThe structure in which products are distributed in large quantities without sufficient product descriptions increases the risk of misuse and overdose by young people.
In addition, the industry associationJapan Cannabinoid Federation (JCF)As a result of prioritizing market expansion, JCF has been unable to take adequate corrective measures against members who engage in problematic sales practices, which has led to a situation in which it has lost public trust.
At the same time, JCFChange.orgWe are conducting a signature campaign through theDeregulation"not,Public-Private Consultation ForumThe purpose is to establish aCBDDiet groupAlthough efforts are being made through theNot publicly disclosed enoughHowever, transparency of activities remains a challenge.
The most important thing is not to get emotionally involved in discussing whether or not regulations should be put in place, but to calmly examine what sales practices are causing the problems.If we limit ourselves to criticizing the administration, similar problems will arise.recurrenceThere is likely to be.
Impact of CBN Regulation on Citizens
- Total ban on CBN products
- Effects of CBD products containing trace amounts of CBN
- Loss of choice for those who used it legally
- Research stagnation
- Growing distrust of government
Inadequate explanations lead to worsening distrust of the government
In this CBN regulation,The biggest concern is the loss of trust in governmentAccountability is not being met in the following areas:
| problem | Specific issues | Impact on citizens |
|---|---|---|
| Uncertainty about causality | The Minister of Health, Labour and Welfare himself acknowledges that "proof is difficult" but is pushing ahead with the regulations | Doubts about scientific evidence |
| Lack of evidence | No data showing a direct link between the accident and CBN was presented | Distrust of "Is this an emotional decision?" |
| Insufficient consideration of alternatives | No discussion of gradual measures such as age restrictions or dosage restrictions | Impression: "hasty and one-sided" |
| Disregarding the voices of those involved | Insufficient research into the impact on legitimate users | "We are being ignored" |
| Deviation from international standards | Lack of consideration of the latest overseas research and expert opinions | "Japan is the only country lagging behind" |
Why is distrust of government a problem?
Distrust in government has a negative impact on society as a whole.
- Declining cooperation with future health policies: Resignation that "the voices of the citizens will never be heard"
- Risk of expanding underground marketPeople who don't trust regulations turn to illegal routes
- Widening disparities in access to medical care: Only those with information and funds can obtain it from overseas
- Stagnation of scientific debateA feeling of helplessness: "It's already decided"
- The public comment system has become a mere formality: The widespread perception that it is useless to give opinions
Overseas experts point out the importance of accountability
Drug Policy AllianceThe 2025 report fromTransparency and accountabilityThe importance of is emphasized.
"Effective drug policy involves evidence-based decision-making, stakeholder engagement, andClear accountability mechanismsis essential.”
Drug Policy Alliance
National Academies of Sciencesalso presents the following principles for policymaking:
- Transparent disclosure of evidence
- Dialogue with various stakeholders
- Consider a phased approach
- Continuous implementation of policy evaluation
Specific examples of failure to fulfill "accountability"
Accident report confidentiality
- Details of the accident (amount ingested, product information, other factors) are unknown
- The results of the scientific analysis claiming that CBN is the cause have not been made public.
- Regulatory decisions made without the ability to verify causal relationships
Lack of discussion of alternatives
- No consideration of age restrictions (ban on sales to those under 18)
- No consideration of dosage restrictions (only high-concentration products)
- No consideration of strengthening labeling obligations (specifying risk information)
Lack of impact studies
- No information on the current number of legal users
- No investigation into actual medical use
- No predicted health impacts from regulations
[Failure to conduct a Regulatory Impact Assessment (RIA)]
Ministry of Internal Affairs and Communications "Guidelines for the Implementation of Policy Evaluation of Regulations" (partially revised on March 15, 2024)So, when establishing, amending or abolishing regulations,Conduct pre- and post-regulation analyses of the impact (costs) of regulations, the effects (benefits) obtained, and the availability of alternatives.This is what is required.
However, the CBN regulations do not include the following basic research and analysis:
Ministry of Internal Affairs and Communications "Laws, Basic Policies, Guidelines, etc. Concerning Policy Evaluation",Euromonitor International, "Changes in the Japanese cannabis market in 2024 and the impact of legal regulations" (January 2024)
- Estimated number of usersIt is estimated that the Japanese CBD market will reach approximately 244 billion yen in 2024, with approximately 53 users.Euromonitor International, 2024), there are no surveys on the number of users of CBN products or their actual usage.
- Actual medical use: No data has been collected on how many people use it to relieve menopausal or PMS symptoms.
- Cost-benefit analysis of regulations: The balance between the options lost due to regulations and the safety gained has not been objectively analyzed.
- Considering alternatives: No comparative study of step-by-step approaches such as age restrictions, dosage restrictions, and strengthened labeling requirements
[Reference: The importance of drug use surveys]
Department of Drug Dependence Research, National Center of Neurology and PsychiatryAs part of the Ministry of Health, Labour and Welfare's scientific research, the Ministry of Health, Labour and Welfare is continuously conducting a "nationwide survey to understand the actual state of drug abuse and dependence" (Principal Investigator: Takuya Shimane).
This survey aims to scientifically grasp the actual state of illegal drug use and provide basic data for policy formulation.FY5 SurveyThe report estimates that there are approximately 134 million people who have used cannabis in their lifetime, and approximately 200,000 who have used it within the past year.
A similar scientific approach is needed for legally used CBN products.However, this has not been implemented in this regulatory process.
National Center of Neurology and Psychiatry "Nationwide Survey on Drug Use" (5)
Calls for constructive dialogue
Importantly,Calling for not just "opposition to regulation" but also "scientific and transparent discussion".
When government agencies establish new regulations, the law requires them to:
Enforcement Order of the Law Concerning the Evaluation of Policies by Administrative Organs (Cabinet Order No. 323 of 2001), revised and enforced on October 1, 2007
- Clarifying the purpose, content and necessity of regulations
- Conduct evaluations based on fair and objective data and information.
- Analyzing the impact (costs) and benefits of regulations
- Consider whether there are alternatives
What citizens want
- Disclosure of scientific evidence: Why CBN is dangerous, show us the data
- Dialogue with the parties involvedListen to what people are saying:
- Involvement of experts: Objective evaluation by medical and pharmaceutical experts
- A phased approach: Rather than a complete ban, we should take a gradual approach
- AccountabilityExplain the decision-making process clearly
If regulations proceed without meeting these requirements, it will undermine not only the CBN issue but also public confidence in all future health policies..
Latest research reveals the effects of CBN
University of Sydney's groundbreaking research (November 2024)
Lambert Initiative for Cannabinoid TherapeuticsThe research team, published in the journal Neuropsychopharmacology, is the world's firstObjectively Measured Effects of CBN on SleepWe have demonstrated that:
"For decades, there has been lore that old-fashioned cannabis induces sleepiness due to the accumulation of CBN, but convincing evidence has been lacking. Our study provides the first objective evidence that CBN improves sleep."
Principal InvestigatorProfessor Jonathon Arnold
Key findings
| research project | Result |
|---|---|
| NREM sleep(deep sleep) | Significantly increased |
| REM sleep(Dreaming sleep) | Significantly increased |
| Total sleep time | increase |
| Targets for comparison | Same effect as zolpidem (sleeping pill) |
| psychoactive | Unlike THC, it has no intoxicating effects |
Human clinical trials (June 2024)
Dr. Marcel O. Bonn-MillerIn a double-blind, placebo-controlled trial (N=293) published in the journal Experimental and Clinical Psychopharmacology, a research team led by Dr.
- 20mg CBN administration group: Significantly reduced number of nighttime awakenings
- Overall sleep disorders: Significant improvement compared to placebo
- Daytime fatigue: No effect
- Use with CBD: No additional effect
Important findingsCBN alone at 20mg is most effective, with minimal side effects (only a mild headache).
Comparative study with melatonin (April 2024)
A study published in Oxford Academic (SLEEP journal)
| Dose | Improves sleep | Side effects |
|---|---|---|
| CBN 50mg | Equivalent to 4mg or more of melatonin | Mild to moderate only |
| CBN 25mg | Significant improvement compared to placebo | Mild to moderate only |
| CBN 100mg | Significant improvement compared to placebo | Mild to moderate only |
| Melatonin 4mg | Significant improvement compared to placebo | Mild to moderate only |
Researchers' conclusions"CBN is particularly promising given the side effects of melatonin and concerns about children exceeding recommended doses."
Voices of the people involved, options lost
Testimonials from women who used CBN for menopausal symptoms
Mr. A (52 years old, office worker) "Hormone therapy caused severe breast tenderness and nausea, so I couldn't continue. Since I started using CBN, I went from waking up 3-4 times a night to almost always being able to sleep until the morning. My work performance has also improved. If this goes away, I'll go back to my old life..."
B (48 years old, nurse) "I work night shifts, so the quality of my sleep is a matter of life and death. Sleeping pills leave you feeling slept the next day, and I'm worried about the possibility of addiction. CBN helps me sleep more naturally and wake up feeling refreshed.I finally found a method that suits me'
Voices of women who used CBN for PMS
Mr. C (35 years old, designer) "I suffered from severe headaches and back pain for two weeks before my period, and I was taking painkillers three times a day. Since I started using CBN, the pain has subsided and I've been able to reduce the amount of medication I take. Considering the risks of long-term painkiller use, CBN was a valuable alternative."
Overseas experts talk about harm reduction
National Academies of Sciences opinion
The comprehensive report, "Cannabis Policy Impacts Public Health and Health Equity," released in November 2024,Harm Reduction ApproachesThe importance of is emphasized.
"Harm reduction is a set of approaches that reduce the health and safety risks to individuals and society associated with drug use and other behaviors.Policy development is crucial to minimizing the potential harms of cannabis use and promoting health equity"
Cannabis Policy Impacts Public Health and Health Equity
Drug Policy Alliance Recommendations
The report, "State Level Marijuana Reform: Lessons Learned and Ongoing Challenges," was released in July 2025.
Key principles
- Putting consumer education at the center
- Restricting product designs that target vulnerable groups, such as young people
- Product labels clearly state efficacy and health warnings
- Promoting harm reduction and expanding treatment options
Doctors for Drug Policy Reform (D4DPR) Position
D4DPR, an international organization of medical professionals,Evidence-based drug policyWe advocate the following.
D4DPR Goals
- Maximizing Health and Wellness
- Harm reduction
- Cannabis andサイケデリックLegalization of
- Advancing public health, human rights, and social justice
Former U.S. Surgeon General Joycelyn Elders and others published "The Physicians' Case for Marijuana Legalization" in the American Journal of Public Health, arguing that prohibition policies cause greater harm to public health than to the public.doing.
Canada's Lower-Risk Cannabis Use Guidelines
The Lower-Risk Cannabis Use Guidelines (LRCUG), developed by Canadian researchers, state the following:Modifiable risk factorshas been identified.
| Risk factors | Recommended actions |
|---|---|
| Age at which use begins | Delay until adolescence or later |
| THC content | Avoid high-THC products |
| frequency of use | Avoid high-frequency and high-intensity use |
| Route of administration | Avoid smoking |
Key PointsCBN has mild psychoactive effects and does not present many of these risk factors.
What we can do: A guide to submitting public comments
What is a public comment?
Public comments (public opinion solicitation)An important system that allows citizens to participate in policy-makingThe submitted opinions will be taken into consideration when deciding on ministerial ordinances and notifications.
Deadline and submission method
Deadline: Saturday, December 28, 2025, midnight
Submission URL : https://public-comment.e-gov.go.jp/servlet/Public?CLASSNAME=PCMMSTDETAIL&id=%20495250249&Mode=0
How to write effective public comments
Describe your actual experience in detail
Good example"I'm a 48-year-old office worker who has suffered from insomnia due to menopausal symptoms for three years. I couldn't continue hormone therapy due to side effects, and I was worried about the addictive nature of sleeping pills. Since using CBN, my sleep quality has improved, and my work performance has recovered. I'm concerned that this regulation will take away options from women in my situation."
Citing scientific evidence
Points to cite
- University of Sydney research (November 2024)
- Double-blind, placebo-controlled study (June 2024)
- Opinions of overseas expert groups
Present alternatives
- Age-restricted sales
- Dosage restrictions
- Strengthening quality control
- Enhancement of user education
Pointing out the impact of regulations
- Impact on CBD products
- Violation of the rights of legitimate users
- Stagnation of research and development
- Lack of harm reduction perspective
Public comment template
厚生労働大臣 殿
私は[年齢]歳の[職業]です。今回のCBN規制案について、法哲学における正義論、および現代行政倫理の観点から、深刻な懸念を表明いたします。
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
■ 1. 私の状況と、失われようとしているもの
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
私は[更年期症状/PMS]により、以下の症状に長年苦しんできました。
- [具体的症状:不眠、痛み、イライラなど]
- [日常生活への影響]
ホルモン補充療法は[副作用/既往症]により使用できず、睡眠薬は[依存性への懸念/副作用]から避けてきました。CBNは、私にとって数少ない選択肢の一つでした。
使用後、[具体的な改善内容]となり、[仕事/家族生活/社会参加]が可能になりました。これは単なる「便利な商品」ではなく、私の人間らしい生活を支える基盤です。
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
■ 2. ロールズの正義論から見た本規制の問題
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
現代正義論の基礎を築いたジョン・ロールズは、「公正としての正義」において、社会制度を評価する際の重要な原理を提示しました。その核心は「無知のベール」という思考実験です。
もし政策立案者の皆様が、自分が誰か(健康な人か、持病がある人か、ホルモン療法が使える人か使えない人か)を知らない状態で政策を決めるとしたら、どのような判断をされるでしょうか。
ロールズの格差原理は明確です。「社会的・経済的不平等は、最も不利な立場にある人々の状況を改善する場合にのみ許容される」
本規制は、この原理に真っ向から反します。
- ホルモン療法が使えない女性たち
- 睡眠薬が合わない人々
- 既存の治療法にアクセスできない人々
私たちこそが「最も不利な立場」にいる当事者です。 本規制は、私たちの状況を改善するどころか、最後の選択肢を奪います。
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
■ 3. 行政倫理における「説明責任」の本質
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
「説明責任(Accountability)」は、単に「説明すれば終わり」ではありません。これは日本特有の誤訳です(岡芳明・東京大学名誉教授、2024)。
本来の意味は「結果に対する責任」です。つまり、なぜその判断をしたのか。その判断が市民にどのような影響を与えるか。判断を正当化する根拠は十分か。その結果に責任を持てるか。
今回の規制において、以下の点で説明責任が果たされていません。
【科学的根拠の不透明性】
- 事故とCBNの因果関係:厚労相自身が「証明は困難」と認めている
- 事故の詳細データ(摂取量、製品情報、他の要因):非公開
- 科学的分析結果:提示なし
これで「結果に対する責任」を負えるのでしょうか。
【代替案の検討不足】
海外では以下のような段階的アプローチが検討されています。
- 年齢制限(18歳未満への販売禁止)
- 用量規制(高濃度製品のみ規制)
- 表示義務強化(リスク情報の明記)
- 消費者教育の充実
なぜ日本では、いきなり全面禁止なのでしょうか。
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
■ 4. 行政手続法が求める「公正」と「透明性」
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
行政手続法第1条は明確に定めています。
「行政運営における公正の確保と透明性の向上を図り、国民の権利利益の保護に資することを目的とする」
本規制プロセスは、この法の精神に反しています。
【公正性の欠如】
- 当事者(合法的使用者)への影響調査:実施されず
- 医療専門家・薬学専門家の意見聴取:不十分
- 利害関係者との対話:形式的
【透明性の欠如】
- 規制判断の科学的根拠:不明確
- 代替案の検討過程:非公開
- 影響評価(どれだけの人が影響を受けるか):なし
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
■ 5. 最も恵まれない人々への配慮という道徳的義務
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
私たち更年期・PMS症状に苦しむ女性の多くは。
- 既存の治療法が使えない
- 経済的に高価な代替療法にアクセスできない
- 症状のために社会参加が制限されている
ロールズの言葉を借りれば、私たちは「社会の中で最も不利な立場にある人々」です。
行政には、功利主義的に「多数の安全」だけを考えるのではなく、最も弱い立場にある人々を守る義務があります。
本規制は、一つの事故(因果関係不明)を理由に、何千人もの合法的使用者から選択肢を奪います。これは正義に適っているでしょうか。
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
■ 6. 私が求めること
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
規制そのものに反対しているのではありません。適切な規制は必要です。
しかし、以下を求めます。
【1】科学的根拠の完全な開示
- 事故とCBNの因果関係を示すデータ
- リスク評価の詳細
- 海外研究のレビュー結果
【2】段階的アプローチの検討
- 年齢制限、用量規制、表示義務などの代替案
- 研究継続の余地
- 医療目的使用の例外措置
【3】当事者との対話
- 合法的使用者の実態調査
- 医療専門家・薬学専門家の参画
- 影響を受ける人々の声を聞く場
【4】透明な意思決定プロセス
- 判断根拠の明示
- 検討過程の公開
- 結果に対する責任の明確化
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
■ 7. 最後に、厚生労働省の皆様へ
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
皆様も、いつか「最も不利な立場」に立つかもしれません。
- ご自身やご家族が、標準治療が効かない病気に苦しむかもしれません
- 既存の選択肢がすべて使えない状況に陥るかもしれません
- やっと見つけた「自分に合う方法」が、ある日突然奪われるかもしれません
「無知のベール」を被って、もう一度考えてみてください。
この規制が、本当に「公正」で「正義に適った」ものなのか。
最も弱い立場にある人々を、さらに追い詰めることにならないか。
行政手続法が求める「公正の確保」と「透明性の向上」、そしてロールズの正義論が示す「最も不利な立場にある人々への配慮」。
これらは理念ではなく、行政が果たすべき道徳的義務です。
本パブリックコメントを通じて、皆様の良心に訴えます。
拙速な規制ではなく、科学的根拠に基づいた、透明で公正な、そして最も弱い立場にある人々を守る政策決定を、心から求めます。
私たちの声が、真摯に検討されることを信じています。
令和6年12月[日付]
[氏名]
[連絡先](任意)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
参考文献:
- John Rawls『正義論』(1971)
- 岡芳明「日本には行政の結果に対する責任を問う仕組みがない」(2024)
- 行政手続法(平成5年法律第88号)
- Arnold, J. et al. "A sleepy cannabis constituent: cannabinol", Neuropsychopharmacology (2024)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
In summary, the importance of speaking up
The scientific evidence is clearSeveral peer-reviewed studies published in 2024 have demonstrated the sleep-improving effects and safety of CBN.Harm reduction-based policiesemphasizes the importance of
However, in Japan, regulations are being implemented without a clear causal relationship..
CBN is one of the few alternative options for women suffering from menopausal and PMS symptoms. Women who cannot use hormone therapy, are concerned about the side effects of sleeping pills, or want to avoid long-term use of painkillers are now being listened to.
Make your voice heard by Sunday, December 28, 2025.
Public comments are a valuable opportunity for us to participate in policy-making. Opinions based on individual experiences and scientific evidence will lead to better policies.
Act now to protect your health choices.
References and Resources
Reference document
- Arnold, J. et al. (2024) "A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats", Neuropsychopharmacology
- Bonn-Miller, M.O. et al. (2024) "A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality", Experimental and Clinical Psychopharmacology
- National Academies of Sciences (2024) "Cannabis Policy Impacts Public Health and Health Equity"
- Drug Policy Alliance (2025) "State Level Marijuana Reform: Lessons Learned and Ongoing Challenges"
Cover image
- Photo by Slumber Sleep Aid on Unsplash

![Mail-order product: MDMA × MM Analog [For Research Use]](https://www.thch-vape.shop/html/user_data/assets/img/products/213_250x250.webp)


